Nothing gets me more excited than a brand new week of trading opportunities to be made alongside financial professional insight.
Today I’ve outlined a trading opportunity which I believe could lead to profit, and I’ve prepared an exclusive report for you.
| Ticker Code | Ticker Name | Ticker Industry | Price Change | Average Volume (50)* |
| NBIX | Neurocrine Biosciences Inc | Biotechnology | 3.81% | 819,896 |
| OPGN | Opgen Inc | Diagnostics & Research | -22.60% | 887,300 |
| ZOM | Zomedica Pharmaceuticals Corp | Drug Manufacturers – Specialty & Generic | 24.00% | 32,831,401 |
| SCYX | Scynexis Inc | Drug Manufacturers – Specialty & Generic | 7.14% | 1,142,561 |
| TUES | Tuesday Morning Corp | Discount Stores | -107.14% | 1,637,651 |
| ROKU | Roku Inc | Pay TV | 33.82% | 12,781,878 |
| TXMD | TherapeuticsMD Inc | Drug Manufacturers – Specialty & Generic | 19.08% | 5,664,626 |
| HHT | China Advanced Construction Materials Group Inc | Building Materials | -22.22% | 891,906 |
| MVIS | Microvision Inc | Scientific & Technical Instruments | 8.87% | 33,818,165 |
| ONTX | Onconova Therapeutics Inc | Biotechnology | 16.67% | 5,015,068 |
| TRPX | Therapix Biosciences Ltd | Biotechnology | -4.88% | 2,836,328 |
| GOOG | Kitov Pharma Ltd | Internet Content & Information | 17.14% | 2,127,956 |
| KTOV | Alphabet Inc | Biotechnology | 36.73% | 11,687,819 |
| AAPL | Fuelcell Energy Inc | Consumer Electronics | 1.57% | 39,573,757 |
| FCEL | Apple Inc | Electrical Equipment & Parts | 26.70% | 8,386,688 |
| MARK | Remark Holdings Inc | Internet Content & Information | 72.12% | 26,083,328 |
| AMZN | Amazon Com Inc | Internet Retail | 1.24% | 5,629,197 |
| SQBG | Sequential Brands Group Inc | Apparel Manufacturing | 12.50% | 962,584 |
| TTNP | Titan Pharmaceuticals Inc | Biotechnology | 28.13% | 8,310,046 |
| V | Visa | Credit Services | -0.83% | 14,335,145 |
While we have heard some rumors of the economy reviving, reopening venues and destinations will come with risk, extensive safety measures, and speculation.
One headline remains consistent time and time again… In order to reopen an economy which has been slashed as a result of the coronavirus pandemic, we need a vaccine which passes tests positive, and is effective as well.
Neither of those will be easy to complete successfully – and definitely won’t happen overnight.
There is, however, one company which financial professionals and even the talking heads on television remain optimistic on to be the company which officially releases an effective vaccine, is capable of helping mass amounts of individuals, and ideally results in the economy being able to reopen in full.
Gilead Sciences (NYSE: GILD) might be the only stock which went up during March’s epic stock market selloff.
Why?
In the eyes of financial professionals and politicians, Gilead may be the first company to develop, test, and release an effective vaccine – which at this point is pretty much a necessity in order to reopen the economy.
In the eyes of a trader, not only does this catalyst bring optimism to Gilead’s stock itself, it is also creating an easy to read trading trend, which I’ll be looking for today and through this week – as I expect financial professionals to be doing the exact same…
In the chart above you’ll notice Gilead’s 50-day simple moving average line in red. Should Gilead trade above its 50-day simple moving average line, I’ll be interested in making a bullish trade, and collecting quick profits.
With an optimistic catalyst in place and a clear technical trading plan laid out, I expect Gilead to make for a nice and easy trade, and who doesn’t love easy.
Yours for TrackStar trading,
Davis Martin
America’s #1 Premarket and Day Trader
Disclaimer: This is not investment advice. This article is for information purposes only and opinion-based on financial advisor data across a selection of websites. Investors should be cautious about any and all investments and are advised to conduct their own due diligence prior to making any investment decisions.